Biology of T Cells - Part B
Biology of T Cells - Part B, Volume 342, the latest release in the International Review of Cell and Molecular Biology series, offers an overview of the major molecular and cellular aspects of T-cell biology and their links to human pathophysiology. Chapters in this release include Metabolism of T lymphocytes in health and disease, T lymphocytes and autoimmunity, Cancer immunosurveillance by T cells, T lymphocytes as targets in viral disorders, Molecular mechanisms underlying pharmacological immunosuppression, T lymphocyte-based immunotherapeutics, In silico methods to analyze T cell biology, and Engineering Platforms for T Cell Modulation.
1. Metabolism of T lymphocytes in health and disease Timo Gaber 2. T lymphocytes and autoimmunity Uqba Khan 3. Cancer immunosurveillance by T cells Arnold Han 4. T lymphocytes as targets in viral disorders Anne Monette 5. Molecular mechanisms underlying pharmacological immunosuppression Nicolas Pallet and Marie-Anne Loirot 6. T lymphocyte-based immunotherapeutics Saman Maleki Vareki 7. In silico methods to analyze T cell biology Sebastiano Battaglia 8. Engineering Platforms for T Cell Modulation Jonathan Schneck
The book (which consists of two parts, part A and part B) is equally addressed to expert investigators who may wish to expand their knowledge on the biology of T cells, and to newcomers to this exciting and rapidly expanding area of research.
- Contains individual chapters that focus on one specific facet of the development, phenotype, function, study or pathophysiological relevance of T lymphocytes
- Presents the latest release in the International Review of Cell and Molecular Biology series
Date de parution : 01-2019
Ouvrage de 318 p.
15x22.8 cm
Thème de Biology of T Cells - Part B :
Mots-clés :
Adoptive cell therapy; Antigen Antigen-presenting cells; Antigen presentation; Artificial aAntigen -pPresenting cCells; Autoimmune diseases; Autoimmunity; Cancer immunotherapy; Cancer; Cell eEngineering; Combination drug therapy; Combination iImmunotherapies; Cytokines; Glucose; Immune checkpoint inhibitors; Immunoengineering; immunometabolism; Immunometabolism; Immunosuppression; Immunosuppressive drugs; Immunotherapy; Macrophage; Major histocompatibility complex; Metabolic checkpoint; Metabolism; Mitochondria; Particles; Protein eEngineering; Scaffolds; Self-tolerance; T cell receptor; T cell; T CellcellTissue eEngineering; T cells; T lymphocytes; Tregs; Tumor Tumor-associated macrophage; Tumor vaccines